How Much Does Ozempic Cost Per Month in 2026?

In October 2026, Ozempic costs $349 a month without insurance for doses up to 1 mg and $499 a month for the 2 mg dose when you buy it directly from Novo Nordisk. New patients can get the first two months for $199 each through December 31, 2026. Ozempic tablets start at $149 a month. With commercial insurance that covers it, many people pay as little as $25. The official list price is about $1,000 a month, but very few people should be paying that.

What you actually pay depends on three things: whether you have insurance, whether you have type 2 diabetes, and which dose you're on. Here's the full breakdown, plus what changes on January 1, 2027.

If you're paying cash, don't pay a pharmacy's retail price. Novo Nordisk sells Ozempic directly through NovoCare Pharmacy, and the same self-pay prices are listed on the government's TrumpRx.gov site. The pen costs $349 a month at the 0.25, 0.5 or 1 mg doses and $499 at 2 mg. If you're new to Ozempic, the first two fills at the starting doses are $199 each through the end of 2026.

Two things people miss. First, the price is tied to your dose, so plan for your maintenance dose, not your starting one: someone who ends up on 2 mg will pay $499 a month, or about $6,000 a year. Second, self-pay purchases happen outside your insurance, so they usually don't count toward your deductible.

With commercial insurance and a type 2 diabetes diagnosis, Ozempic is usually covered, often after prior authorization. Your cost is your plan's copay or coinsurance for its tier. If you're eligible, the Ozempic savings card can lower that to as little as $25 a month, with a maximum benefit of $100 a month. The card doesn't work with Medicare, Medicaid or other government insurance.

Without diabetes, most plans deny Ozempic because it isn't approved for weight loss. If your plan covers weight-loss drugs at all, it will usually cover Wegovy, Zepbound or Foundayo instead. Our insurance guide explains how to check your plan, get prior authorization and appeal a denial.

Medicare Part D plans cover Ozempic for type 2 diabetes. What you pay depends on your plan's tier and deductible, which can be up to $615 in 2026, but your total out-of-pocket spending on covered drugs is capped at $2,100 for the year. For someone on Ozempic plus other brand-name drugs, that cap is often what matters most.

Ozempic isn't part of the Medicare GLP-1 Bridge, the $50-a-month program for weight-loss GLP-1s that started in July 2026; that covers drugs like Wegovy, Zepbound and Foundayo for eligible members without diabetes. Starting in 2027, Medicare's negotiated price for semaglutide drops to $274 for a 30-day supply, which lowers what Medicare pays. How much it lowers your copay depends on your plan.

With Ozempic now at $349 for most doses, the savings from compounded or online semaglutide have shrunk to the point where they rarely justify the risks. Those products aren't FDA-approved, and the biggest documented danger is dosing errors from vials measured in units. Our compounded semaglutide guide explains the difference.

Most people shouldn't pay anywhere near Ozempic's list price. With insurance and type 2 diabetes, it can cost as little as $25 a month. Without insurance, it's $349 a month for most doses and $499 at 2 mg, with a $199 introductory price for new patients through the end of 2026, and tablets from $149. If you're using it for weight loss without diabetes, compare it against Wegovy and the newer pills before you commit, because the cheapest option may not be Ozempic.